Showing results (1751-1760 of 7,887) with videos related to
Sort By:
Pageof 789
Eye (London, England)|November 6, 2025
Intravitreal anti-VEGF therapy for extrafoveal macular neovascularisation secondary to age-related macular degeneration: five-year results in a tertiary centreFaik Gelisken, Nurullah Koçak, Caroline J Wenzel, et al.Eye (London, England)|July 7, 2025
Gonioscopy-assisted transluminal trabeculotomy outcomes in patients with highly advanced glaucomaLeopoldo Magacho, Cláudia Gomide Vilela de S Franco, Eduardo Akio I, et al.Eye (London, England)|July 9, 2025
Role of microperimetry to detect early visual function deficits in patients with hydroxychloroquine retinal toxicity-a reviewPriya R Chandrasekaran, Anna C S TanEye (London, England)|July 2, 2025
Wide-field OCTA quantified peripheral nonperfusion areas predict the risk of subclinical neovascularizationAn-Lun Wu, Yukun Guo, Tristan T Hormel, et al.Eye (London, England)|September 18, 2025
Keratoconus prevalence in astigmatic adolescents: findings from a nationwide screening settingMargarita Safir, Itay Nitzan, Yair Hanina, et al.Eye (London, England)|September 19, 2025
Cost-effectiveness of anti-vascular endothelial growth factor and macular laser treatments for people with centre-involving diabetic macular oedema and central retinal thickness of at least 400 micrometresKirsty Luckham, Hannah Tebbs, Clare Dadswell, et al.Eye (London, England)|October 11, 2025
Novel targets beyond vascular endothelial growth factor-A inhibition: improving vision with neovascular age-related macular degeneration treatmentArshad M Khanani, Sophie J Bakri, Carl Regillo, et al.Eye (London, England)|October 15, 2025
A 20-year review of orbital biopsy at the Newcastle Eye CentreYanmei Chen, William Hodgkinson, Fraser Charlton, et al.Eye (London, England)|September 22, 2025
Initial circumpapillary retinal nerve fibre layer rates of change predict glaucomatous progressionVincent Q Pham, Takashi Nishida, Sasan Moghimi, et al.Eye (London, England)|September 19, 2025
Dual site external validation of artificial intelligence-enabled treatment monitoring for neovascular age-related macular degeneration in EnglandHenry David Jeffry Hogg, S James Talks, Justin Engelmann, et al.Pageof 789